Hologic Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Nov 30, 2021 / 02:40PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD

Okay. Thanks, everyone, for joining us. I'm Vijay Kumar, cover med tech and tools here at Evercore. Pleasure to have Hologic with us. We have CFO, Karleen Oberton; and the new Head of IR, Ryan Simon, with us.

Questions and Answers:

Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD

Maybe, Karleen, to kick things off, a lot of questions around this new variant, Omicron, and -- can these molecular diagnostic tests, whether it's PCR antigen detect them, can your test, COVID test detect the new variant? And maybe we'll start there.

Karleen M. Oberton - Hologic, Inc. - CFO

Vijay, it's a pleasure to be here with you today. Yes, we actually issued a press release on that, that confirming that all three of our COVID-19 tests do pick up the new Omicron variant. We specifically designed our test with the idea that there would be mutations in the future. And so we do have affirmation that we do
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot